Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
- 12 May 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 9 (6), 762-767
- https://doi.org/10.1038/nm875
Abstract
In monkeys rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), expression of the dopamine D3 receptor was decreased. However, levodopa-induced dyskinesia (LID), similar to the debilitating and pharmacoresistant involuntary movements elicited after long-term treatment with levodopa in patients with Parkinson disease (PD), was associated with overexpression of this receptor. Administration of a D3 receptor–selective partial agonist strongly attenuated levodopa-induced dyskinesia, but left unaffected the therapeutic effect of levodopa. In contrast, attenuation of dyskinesia by D3 receptor antagonists was accompanied by the reappearance of PD-like symptoms. These results indicated that the D3 receptor participated in both dyskinesia and the therapeutic action of levodopa, and that partial agonists may normalize D3 receptor function and correct side effects of levodopa therapy in patients with PD.This publication has 29 references indexed in Scilit:
- A Paradigm Shift in Brain ResearchScience, 2001
- Pathophysiology of levodopa-induced dyskinesia: Potential for new therapiesNature Reviews Neuroscience, 2001
- Identification of the dopamine autoreceptor in the guinea-pig retina as D2 receptor using novel subtype-selective antagonistsBritish Journal of Pharmacology, 2001
- Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's diseaseMovement Disorders, 1998
- D3 receptor expression within the basal ganglia is not affected by Parkinson's diseaseNeuroscience Letters, 1996
- Chronic L‐DOPA administration induces dyskinesias in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐treated common marmoset (Callithrix jacchus)Movement Disorders, 1995
- Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptorsNature, 1995
- Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell lineEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal NeuronsScience, 1990